Trexquant Investment’s Nurix Therapeutics NRIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $587K | Buy |
+51,533
| New | +$587K | 0.01% | 1221 |
|
|
2025
Q1 | – | Sell |
-22,527
| Closed | -$424K | – | 1771 |
|
|
2024
Q4 | $424K | Sell |
22,527
-136,734
| -86% | -$2.58M | ﹤0.01% | 1323 |
|
|
2024
Q3 | $3.58M | Sell |
159,261
-79,321
| -33% | -$1.78M | 0.05% | 608 |
|
|
2024
Q2 | $4.98M | Buy |
238,582
+25,703
| +12% | +$536K | 0.08% | 405 |
|
|
2024
Q1 | $3.13M | Buy |
212,879
+53,561
| +34% | +$787K | 0.06% | 476 |
|
|
2023
Q4 | $1.64M | Buy |
159,318
+71,252
| +81% | +$735K | 0.04% | 622 |
|
|
2023
Q3 | $692K | Buy |
88,066
+32,212
| +58% | +$253K | 0.02% | 889 |
|
|
2023
Q2 | $558K | Buy |
55,854
+21,107
| +61% | +$211K | 0.01% | 963 |
|
|
2023
Q1 | $309K | Buy |
34,747
+7,697
| +28% | +$68.3K | 0.01% | 1188 |
|
|
2022
Q4 | $297K | Buy |
27,050
+2,064
| +8% | +$22.7K | 0.01% | 1110 |
|
|
2022
Q3 | $326K | Buy |
24,986
+14,636
| +141% | +$191K | 0.01% | 992 |
|
|
2022
Q2 | $131K | Sell |
10,350
-33,978
| -77% | -$430K | 0.01% | 1417 |
|
|
2022
Q1 | $621K | Buy |
44,328
+24,696
| +126% | +$346K | 0.03% | 670 |
|
|
2021
Q4 | $568K | Buy |
+19,632
| New | +$568K | 0.04% | 581 |
|
|
2021
Q2 | – | Sell |
-12,337
| Closed | -$384K | – | 1370 |
|
|
2021
Q1 | $384K | Buy |
+12,337
| New | +$384K | 0.04% | 632 |
|